VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY
Abstract
Ovarian hyperstimulation syndrome (OHSS) is a relatively common complication of ovarian stimulation. The pathophysiology of OHSS is characterised by increased capillary permeability. As a consequence of this, there is a fluid shift into third-space causing hemoconcentration, it may contribute to hypercoagulable state, with increased risk
of venous thromboembolism. The article presents modern data on prevention of thromboembolic complication in OHSS patients with special focus on dosage and duration of thromboprophylaxis.
of venous thromboembolism. The article presents modern data on prevention of thromboembolic complication in OHSS patients with special focus on dosage and duration of thromboprophylaxis.
About the Authors
I. E. Zazerskaya
Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg
Russian Federation
Russian Federation
N. A. Osipova
Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg
Russian Federation
Russian Federation
T. V. Vavilova
Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg
Russian Federation
Russian Federation
L. V. Barabanova
Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg
Russian Federation
Russian Federation
K. S. Konradi
Almazov Federal Heart, Blood and Endocrinology Centre, Saint-Petersburg
Russian Federation
Russian Federation
References
1. Berkovskii A.L., Sergeeva E.V., Suvorova A.V., Kozlova A.A. Methods for determining the activity of heparin. Methodological guidance [Metody opredeleniya aktivnosti geparina. Metodicheskoe rukovodstvo]. Moscow. 2011; 54 s.
2. Komissarova Yu.V. Optimizatsiya programmy ekstrakorporal’nogo oplodotvoreniya i perenosa embrionov s uchetom angiogennykh faktorov: avtoref. dis. … kand. med. nauk (Optimization program of in vitro fertilization and embryo transfer with the angiogenic factors) Phd. diss. Moscow. 2010; 33 s.
3. Korneeva I.E. Ovarian hyperstimulation syndrome. In .: sterile marriage. Ed. VI Kulakov [Sindrom giperstimulyatsii yaichnikov. V kn.: Besplodnyi brak. Pod red. V.I. Kulakova]. Moscow. 2006; 449-496.
4. Korneeva I.E., Ivanova A.V., Barkalina N.V. Problemy reproduktsii. 2004; 10 (1): 43-50.
5. Kulakov V.I., Kalinina E.A., Korneeva I.E. i dr. Treatment of ovarian hyperstimulation syndrome. In .: Treatment of female and male infertility. Assisted reproductive technology. Ed. VI Kulakov, BV Leonova, LN Kuz’micheva [Lechenie sindroma giperstimulyatsii yaichnikov. V kn.: Lechenie zhenskogo i muzhskogo besplodiya. Vspomogatel’nye reproduktivnye tekhnologii. Pod red. V.I. Kulakova, B.V. Leonova, L.N. Kuz’micheva]. Moscow. 2005; 447-74. 6. Kudykin M.N. Khirurgiya. 2012; 1: 22-25.
6. Lydina I.V. Tromboz, gemostaz i reologiya. 2012; 4 (52): 41-44.
7. Russian clinical recommendations for diagnosis, treatment and prevention of venous thromboembolic events. Flebologiya. 2010; 4 (2): 6-27.
8. Federal clinical guidelines. Diagnosis and treatment of ovarian hyperstimulation syndrome [Federal’nye klinicheskie rekomendatsii. Diagnostika i lechenie sindroma giperstimulyatsii yaichnikov]. Moscow. 2013; 27 s.
9. Bates S.M., Greer I.A., Pabinger I. et al. American College of Chest Physicians. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008; 133 (6): 844–86.
10. Binder H., Dittrich R., Einhaus F. et al. Update on ovarian hyperstimulation syndrome: part 2 – clinical signs and treatment. Int J Fertil Womens Med. 2007; 52 (2-3): 69-81.
11. Budev M., Arroliga A., Falcone T. Ovarian hyperstimulation syndrome. Crit. Care. Med. 2005; 33: 301-306.
12. Chen C.D., Chen H.F., Lu H.F. et al. Value of serum and follicular fluid cytokine profile in the prediction of moderate to severe ovarian hyperstimulation syndrome. Hum. Reprod. 2000; 15 (5): 1037-42.
13. Chin-Der Chen, Shee-Uan Chen, Yu-Shih Yang Prevention and management of ovatian hyperstimulation syndrome. Best Practice and Research Clinical Obstetrics and Gynaecology. 2012; 26: 812-27.
14. Delvigne A., Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum. Reprod. Update. 2003; 9 (1): 77-96.
15. Delvigne A., Rozenberg S. Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS). A review. Hum. Reprod. 2002; 8: 559-77.
16. Delvigne A., Kostyla K., De Leener A. et al. Metabolic characteristics of women who developed ovarian hyperstimulation syndrome. Hum. Reprod. 2002;17 (8): 1994-96.
17. Delvigne A., Rozenberg S. Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum. Reprod. 2003; 9: 77-96.
18. Garcia-Velasco J., Pellicer A. New concepts in the understanding of the ovarian hyperstimulation syndrome. Curr. Opin. Obstet. Gynecol. 2003; 15: 251-56.
19. Garcia-Velasco J.A., Ariel J.A. Chemokines in human reproduction: immune system interactions. Immunol. Clin. N. Am. 2002; 13: 127-44.
20. Kerkela E., Skottman H., Friden B. et al. Exclusion of coding-region mutations in luteinizing hormone and follicle-stimulating hormone receptor genes as the cause of ovarian hyperstimulation syndrome. Fertil. Steril. 2007; 87 (3): 603-6.
21. Manau D., Fabregues F., Penarrabia J. Vascular endothelial growth factor levels in serum and plasma from patients undergoing controlled ovarian hyperstimulation for IVF. Hum. Reprod. 2007; 22: (3): 669-75.
22. Rizk B. Symposium: Update on prediction and management of OHSS. Genetics of ovarian hyperstimulation. Reprod. Bio.Med. Online. 2009; 19 (1): 14-27.
23. Royal College of Obstetricians and Gynaecologists. Reducing the risk of thrombosis and embolism during pregnancy and the puerperium Green-top. Guideline. 2009; 37a.
24. Rova K., Passmark H., Lindqvist P.G Venous thromboembolism in relation to in vitro fertilization: an approach to determinihg the incidence and increase in risk in succrssful cycles. Fertil. Steril. 2012; 97 (1): 95-100.
25. Schenker J., Weinstein D. Ovarian hyperstimulation syndrome: A current survey. Fertil. Steril. 1978; 30: 255-68.
26. Sharif K.W., Ghunaim S. Management of 273 cases of recurrent implantation failure: results of a combined evidence-based protocol. Reprod Biomed Online. 2010 Sep; 21 (3): 373-80.
27. Shmorgun D., Claman P. The diagnosis and management of ovarian hyperstimulation syndrome. J Obstet. Gynaecol. 2011; 11: 1156-1162.
28. Soares S.R., Gomez R., Simon С. et al. Targeting the vascular endothelial growth factor system to prevent ovarian hyperstimulation syndrome. Hum. Reprod. Update. 2008; 14 (4): 321-33.
29. Stewart J., Hamilton P., Murdoch A. Thromboembolic disease associated with ovarian hyperstimulation and assisted conception techniques. Hum. Reprod. 1997; 12: 2167-73.
30. The management of ovarian hyperstimulation syndrome. Setting standards to improve women’s health. Royal College of Obstetricians and Gynaecologists. Green-top Guideline; 2006. 11 p.
31. The Practice Committee of the American Society for Reproductive Medicine. Ovarian hyperstimulation syndrome. Fertil. Steril. 2004; 82: 81-86.
32.
33.
For citation:
Zazerskaya I.E., Osipova N.A., Vavilova T.V., Barabanova L.V., Konradi K.S. VENOUS THROMBOEMBOLISM IN RELATION TO OVARIAN HYPERSTIMULATION SYNDROME: AN APPROACH TO DETERMINING THE LOW-MOLECULAR-WEIGHT-HEPARIN DOSES AND ACTIVITY. Obstetrics, Gynecology and Reproduction. 2014;8(3):53-58. (In Russ.)
Views: 219
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Email this article 
